CINF
47
2
BA
52
2
DVN
16
3
MS
74
-2
SYF
85
2
DD
56
3
DLTR
34
-4
DG
2
-6
UHS
54
3
TXT
48
2
IBM
54
4
MAS
51
4
BIIB
26
2
MPC
47
3
ALLE
37
5
ILMN
32
-3
WMT
74
2
TGNA
53
2
KMX
58
3
JWN
40
-2
CINF
47
2
BA
52
2
DVN
16
3
MS
74
-2
SYF
85
2
DD
56
3
DLTR
34
-4
DG
2
-6
UHS
54
3
TXT
48
2
IBM
54
4
MAS
51
4
BIIB
26
2
MPC
47
3
ALLE
37
5
ILMN
32
-3
WMT
74
2
TGNA
53
2
KMX
58
3
JWN
40
-2
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
739.49
Seasonality Move:
14.6%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Regeneron Pharmaceuticals Price Quote

$739.49
-3.86 (-0.52%)
(Updated: November 21, 2024 at 10:15 AM ET)

Regeneron Pharmaceuticals Key Stats

Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell
Day range:
$736.01 - $750.69
52-week range:
$750.20 - $1,211.20
Dividend yield:
0%
P/E ratio:
21.92
P/S ratio:
6.33
P/B ratio:
2.86%
Volume:
651.8K
Avg. volume:
805K
1-year change:
-7.27%
Market cap:
$83.7B
Revenue:
$13.1B
EPS:
$40.41

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.2B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.9B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 16.02%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 13.44%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 17.19%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 29.81% 6.38%
Revenue: 10.65% 1.47%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 1,078.11
Upside from Last Price: 45.03%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    173.5M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders